ALL KEYWORDSLocally Advanced Breast Cancer (LABC)Related SpecialistsShowing 3 of 36Neal FischbachMDElizabeth BergerMD, MSMichael CohenuramMDMore Related SpecialistsRelated Clinical TrialsShowing 2 of 5An Open-label, Randomized Phase 3 Study of MK-2870 as a Single Agent and in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast CancerBreast CancerA Phase 1, Multi-center, Open Label First-in-Human Study With ABBV-CLS-579 Alone and in Combination With Anti-PD-1 in Subjects With Locally Advanced or Metastatic TumorsPhase 1 CancersMore Related Clinical Trials
